Pyogenic Granuloma of the Esophagus: A Cause of Dysphagia
Author(s) -
Ludlow David,
Thibodeaux Joel,
Nathan CherieAnn
Publication year - 2010
Publication title -
otolaryngology–head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.232
H-Index - 121
eISSN - 1097-6817
pISSN - 0194-5998
DOI - 10.1016/j.otohns.2010.06.303
Subject(s) - esophagus , dysphagia , pyogenic granuloma , medicine , granuloma , general surgery , surgery , pathology , lesion
and chemotherapy. Major causes of deaths related to head and neck squamous cell carcinoma (HNSCC) are cervical node and distant metastasis. Epithelial-mesenchymal transition (EMT) was identified to be the key role for mediating tumor invasion and metastasis of carcinomas. METHOD: The authors investigated the relationship between proinflammatory mediator and EMT in HNSCC. The author evaluated the immunohistochemical expression of interleukin-1 (IL-1 ), cyclooxygenase-2 (COX-2), Slug and E-cadherin in relationship with histologic differentiation, clinical stage and nodal status in 146 surgical specimens of HNSCC. RESULTS: There was a correlation of increased expression of IL-1 with nodal status, increased expression of COX-2 with histologic differentiation, clinical stage, and nodal status. Increased Slug expression was correlated to histologic differentiation and clinical stage. Decreased E-cadherin expression was correlated to histologic differentiation and nodal status. Significant relation was observed between IL-1 and COX-2. However, significant inverse correlation was observed between Slug and E-cadherin. Significant relation was observed between increased proinflammatory mediator IL-1 /COX-2 expression and increased EMT marker Slug/ E-cadherin expression. CONCLUSION: These results indicate that proinflammatory mediators IL-1 and COX-2 induce EMT through increase of Slug and decrease of E-cadherin. The present findings suggest some anti-inflammatory agents could be used as an adjuvant treatment modality with anti-cancer chemotherapeutic drugs in HNSCC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom